News
Sports
Life
Opinion
Business
Advertise
Obituaries
eNewspaper
Legals
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
NewsOK Local Stocks
NewsOK Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Can/Fite BioPharma Ltd/
Recent news which mentions Can/Fite BioPharma Ltd/
Multiple Shots On Goal: Can-Fite's Late-Stage Clinical Pipeline Hits Positive Results
December 13, 2022
Tickers
CANF
Tags
Market News
CANF
Benzinga
From
Benzinga
This Company Is Racing Toward Providing Comfort And Safety To Millions Of Psoriasis Sufferers
October 27, 2022
Tickers
AMGN
BMY
CANF
Tags
CANF
Market News
Penny Stocks
From
Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
Tickers
ABBV
AMGN
CANF
NVS
Tags
General
ABBV
NVS
From
Benzinga
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
Can/Fite BioPharma Ltd/
Biotech
NVS
From
Benzinga
Psoriasis Drug Providers Looking Over Shoulders At Upcoming Competitor?
February 03, 2022
Tickers
ABBV
AMGN
BMY
CANF
Tags
Biotech
BMY
ABBV
From
Benzinga
A New Oral Therapy for Psoriasis Could Be Coming Soon
January 24, 2022
Tickers
ABBV
AMGN
CANF
NVS
Tags
Biotech
Can/Fite BioPharma Ltd/
Partner Content
From
Benzinga
PRIOR TO PHASE III PSORIASIS DATA RELEASE CAN FITE REPORTS THAT PICLIDENOSON DESTROYS PATHOLOGICAL SKIN CELLS IN VITRO
January 13, 2022
Tickers
CANF
Tags
Benzinga
Penny Stocks
Market News
From
Benzinga
Can-Fite to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference
January 10, 2022
Tickers
CANF
CFBI
Tags
Market News
CANF
CFBI
From
Benzinga
Dawson James - Can-Fite (CANF) Buy Rated - Expected Milestones
January 05, 2022
Tickers
CANF
Tags
Partner Content
Can/Fite BioPharma Ltd/
Press Releases
From
Benzinga
CAN-FITE ISSUES LETTER TO SHAREHOLDERS
January 05, 2022
Tickers
CANF
Tags
Market News
CANF
Benzinga
From
Benzinga
FOLLOWING COMPLETE CLEARANCE OF CANCER LESIONS IN ADVANCED LIVER CANCER PATIENT, CAN-FITE IS FILING PATENT APPLICATIONS FOR THE TREATMENT OF VARIOUS ADVANCED SOLID TUMORS
January 03, 2022
Tickers
CANF
Tags
General
Partner Content
Press Releases
From
Benzinga
Positive Data from Phase IIa Can-Fite NASH Study Published in Leading Peer Reviewed Scientific Journal
October 21, 2021
Tickers
CANF
CFBI
Tags
Benzinga
CFBI
Penny Stocks
From
Benzinga
Hope on the Horizon for Liver Cancer Patients as This Company's Namodenoson Drug Starts Pivotal Phase III Global Trial
October 08, 2021
Tickers
CANF
Tags
General
Health Care
Partner Content
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.